Biblio
Comparison of Subcutaneous versus Intravenous Alemtuzumab for Graft-versus-Host Disease Prophylaxis with Fludarabine/Melphalan Based Conditioning in Matched Unrelated Donor Allogeneic Stem Cell Transplant. Biol Blood Marrow Transplant. 2015.
. Consensus Opinion on Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis. Biol Blood Marrow Transplant. 2016.
Haploidentical allogeneic stem cell transplantation with post-transplant cyclophosphamide and subsequent kidney transplant for patients with severe sickle cell disease with end-stage kidney disease (ESKD). Bone Marrow Transplant. 2023.
Hematopoietic Cell Transplantation for Systemic Mature T-Cell Non-Hodgkin Lymphoma. J Clin Oncol. 2013.
Hematopoietic Transplant-Associated Thrombotic Microangiopathy: Case Report and Review of Diagnosis and Treatments. Clin Adv Hematol Oncol. 2014;12(9):565-573.
. Immune reconstitution inflammatory syndrome in a patient with infection after allogeneic hematopoietic stem cell transplantation. Leuk Lymphoma. 2023:1-3.
. MASP2 levels are elevated in thrombotic microangiopathies: Association with microvascular endothelial cell injury and suppression by anti-MASP2 antibody narsoplimab. Clin Exp Immunol. 2020.
. OUTCOMES OF ALLOGENEIC STEM CELL TRANSPLANT FOR ELDERLY PATIENTS WITH HEMATOLOGIC MALIGNANCIES. Biol Blood Marrow Transplant. 2019.
. Pre-hematopoietic stem cell transplant rituximab for Epstein-Barr Virus and post-transplant lymphoproliferative disorder prophylaxis in alemtuzumab recipients. Transplant Cell Ther. 2022.
Screening Chest CT Prior to Allogenic Hematopoietic Stem Cell Transplantation. Transplant Cell Ther. 2023.